Telix Pharmaceuticals Limited Increase Decrease Through Exercise Of Options
Telix Pharmaceuticals Limited (TLPPF) reported Increase Decrease Through Exercise Of Options of $2.17 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions · last filed 2026-02-20
AUD
| Period end | Increase Decrease Through Exercise Of Options 12 month |
|---|---|
| 2024-12-31 | 999.00K AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 6.65M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 6.04M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Increase Decrease Through Exercise Of Options 12 month |
|---|---|
| 2025-12-31 | $2.17M 20-F · filed 2026-02-20 |
| 2024-12-31 | $660.00K 20-F · filed 2026-02-20 |
| 2023-12-31 | $4.35M 20-F · filed 2026-02-20 |